Bionexus Gene Lab CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Set Fui Chong, Chief Financial Officer of BioNexus Gene Lab Corp, received 96,774 shares of common stock on August 13, 2026.
NASDAQ
Jook Yuen Low, a Director of BioNexus Gene Lab Corp, received 16,129 shares of common stock on August 13, 2026.